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Abstract 
Littoral cell angioma is an uncommon pri-
mary vascular neoplasm of the spleen. It fre-
quently follows a benign course, but cases with
aggressive behavior have been described. We
present a case of this rare disease highlighting
radiological  examinations  showing  a  rapid
increase in the size of the spleen as well as an
increase in the number and size of existing
nodules. We also discuss the relationship of
this disorder to chronic infections and its pos-
sible association with Epstein Barr virus. 
Introduction
Littoral  cell  angiomas  (LCA)  are  primary
vascular  neoplasms  of  the  spleen  with  well-
described morphologic and immunologic char-
acteristics.
1-3 However,  there  is  uncertainty
regarding  their  pathogenesis  and  malignant
potential. Classically, the cells of these tumors
are  CD34
–/CD68
+/CD21
+/CD8
– reflecting  the
reticuloendothelial origin of the littoral cells
that normally line the red pulp sinuses of the
spleen.
4 An  association  of  LCA  with  chronic
infections  and  autoimmunity  has  been
observed and suggested to play a role in the
development of this lesion and its possible pro-
gression to malignancy.
1 An association with
second cancers has also been identified.
5 We
present a case of this rare disease, highlight-
ing  the  prior  history  of  chronic  infections,
extensive immunohistochemical studies, and
serial radiological examinations. 
Case Report
A 60-year-old Caucasian man presented with
abdominal pain and early satiety for the last
five years. Past medical history was remark-
able  for  poliomyelitis  (at  age  4  years),  sub-
acute bacterial endocarditis requiring repair of
the mitral valve (four years previously), and
bilateral pneumonia several months prior to
splenectomy.  The  physical  examination  was
remarkable for splenomegaly extending almost
to the anterior iliac crest and atrophy of both
lower extremities. Laboratory findings includ-
ed  Hb=10.9  g/dL  (range:  13.5-17.0  g/dL),
platelet  count=105  k/cmm  (rage:140-450
k/cmm),  WBC  =7.5  k/cmm  (range:  4.0-10.5
k/cmm),  routine  serum  chemistries  within
normal limits, normal levels of immunoglobu-
lins, and no serum monoclonal protein. A bone
marrow  examination  was  histologically  nor-
mal. Radiographic images were obtained and
compared  to  those  from  five  years  earlier
(Figure 1). A computerized tomography (CT)
scan performed with oral contrast and intra-
venous omnipaque revealed a spleen size of
approximately  25  cm  in  the  cranial-caudal
dimension and 16 cm in the transverse dimen-
sion. This represented a 5x5 cm increase over
the  earlier  examination.  Heterogeneous
enhancement related to confluence of multiple
hypodensities was present on both radiograph-
ic studies, but markedly increased on the sec-
ond study. The differential diagnosis was pri-
marily a low-grade lymphoma. 
Our patient’s symptom of early satiety plus
progressive anemia and thrombocytopenia led
to  a  strong  recommendation  for  an  elective
splenectomy; therefore, he underwent no other
imaging  studies  or  needle  biopsy.  The  large
size of the spleen precluded a laparoscopic pro-
cedure,  and  the  patient  underwent  an  open
splenectomy  without  complications.  The
spleen  weighed  1212  g,  approximately  six
times normal. The external surface had a dif-
fuse  cystic  appearance  with  solid  nodules
ranging in size from 0.2 to 1.8 cm. The cut sur-
face revealed multiple blood-filled cavities and
multiple  solid  nodules  that  were  firm,
gray–tan, and non-necrotic (Figure 2). There
were three tan lymph nodes each measuring
0.5 cm at the hilar region. 
Microscopic evaluation showed dilated vas-
cular  channels  forming  anastomoses,  many
with micro-thrombi. The channels had irregu-
lar lumina and papillary projections containing
enlarged endothelial cells with vesicular nuclei
and  eosinophilic  cytoplasm  (Figure  2).
Exfoliated  histiocytes  were  present  in  the
lumina.  The  lining  cells  showed  no  nuclear
atypia  or  atypical  mitoses.  An  iron  stain
showed extensive siderosis. Staining was pos-
itive with endothelial cell markers PAS, PAS+/-
D, and Factor VIII-related antigen, as well as
the histiocytic marker, CD68. In addition, there
was  intense  expression  of  CD21  and  Ki-67;
however, Epstein Bar nuclear antigen (EBNA)
was negative. An analysis of sinus-lining cells
for the Ki-ras gene revealed only wild type. The
lymph nodes were microscopically normal.
Discussion
The differential diagnosis of an enlarging
multi-nodular  spleen  includes  hemato-
lymphoid  tumors  (e.g.  lymphomas,  either
Hodgkin’s or diffuse large B-cell), granuloma-
tous lesions (e.g. mycobacteriosis, deep fungal
infection, visceral Leishmaniasis), metastatic
carcinoma,  inflammatory  myofibroblastic
tumor,  splenic  hamartomas,  and  relatively
uncommon vascular tumors such as angioma,
hemangioendothelioma,  and  angiosarcoma.
Littoral cell angioma is a rare, recently charac-
terized, vascular neoplasm of the spleen with
immunophenotypic features suggesting an ori-
gin from the littoral cells lining the sinuses of
the  splenic  red  pulp.  There  is  no  gender
predilection and the median age at presenta-
tion is 49 years.
1-2
Imaging studies utilized to evaluate splenic
masses have included ultrasound, CT, magnet-
ic resonance imaging (MRI), and nuclear medi-
cine scans. Ultrasound characteristics of LCA
are nonspecific. CT features of LCA are usual-
ly  iso-attenuating  on  non-contrast  images,
while  contrast  enhancement  reveals  early
hypo-attenuation with arterial and early portal
phases. Technetium 99m red blood cell (RBC)
scans have been suggested as a method to dis-
tinguish  hemangiomas  from  other  lesions
including LCA, as the former are “hot” on RBC 
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scan  with  persistent  signal  intensity  on
delayed images, while two reports have indi-
cated LCA are “cold”. Recent reports have sug-
gested  that  the  MRI  characteristics  of  LCA
depend upon the amount of hemosiderin with-
in the tumor cells. When there is significant
hemosiderin, there is loss of intensity of the
MRI  signal.  This  is  best  demonstrated  on
Gradient Echo sequences. Hemangiomas also
have a typical appearance on dynamic contrast
MRI and can therefore be differentiated from
other masses.
6
The  pathogenesis  is  unclear  but  immune
system dysregulation may explain its frequent
association  with  other  malignancies  and
autoimmune  disorders.
3 Harmon  et  al.
reviewed the literature and tabulated 74 cases
of LCA with 23 (31.1%) having a second pri-
mary cancer; no site predominated.
5 The high
frequency of second cancers emphasizes the
importance  of  continued  surveillance  of
patients with LCA. It is of note that our patient
has a past history of poliomyelitis and repeat-
ed bacterial infections, and we suggest that the
development of LCA may be related to this his-
tory, although the association might be coinci-
dental. 
Epstein  Barr  virus  (EBV)  belongs  to  the
human herpes virus family and is ubiquitously
distributed  all  over  the  world.  It  is  the
causative  agent  of  infectious  mononucleosis
and is associated with several malignancies in
man, such as African endemic Burkitt's lympho-
ma, nasopharyngeal carcinoma of the undiffer-
entiated form, B-cell lymphomas in immuno-
suppressed  individuals,  and  Hodgkin’s  dis-
ease.  The  protein  CD21  is  an  EBV  receptor
found on B-lymphocytes. Its expression in LCA
has been described.
1-2We also were able to con-
firm this observation in our tumor. The pres-
ence of CD 21 on the tumor cells therefore may
be a potential target of therapy. Nuclear anti-
gen 1 (EBNA-1) is a key protein of the EBV, and
it  is  the  only  viral  protein  consistently
expressed  in  EBV-associated  malignancies.
7
Although our patient’s splenic tissue was posi-
tive for CD 21, the EBNA-1 was negative. This
could imply that the EB virus had no etiological
role in this case, or it could reflect technical
difficulties  in  detection.  EBV  also  has  been
associated  with  immune  dysregulation,  and
EBV infection could be the link between LCA
and  autoimmune  conditions  identified  in
patients with LCA.
8 Further studies to clarify a
relationship between EBV and LCA would bene-
fit from a computerized registry to facilitate
tissue acquisition. 
A spleen with LCA grossly may contain mul-
tiple red pulp nodules of variable consistency
and color depending on the degree of necrosis,
cyst formation, thrombi, and fibrosis. The nod-
ules are composed of irregular anastomosing
vascular channels lined by tall endothelial cells
with  vesicular  nuclei,  open  chromatin,  and
small nucleoli. Papillary fronds, prominent cel-
lular  vacuolization,  and  evidence  of  hemo-
phagocytosis and focal aggregates of eosino-
philic globules have been described. Immuno-
histochemical  analysis  reveals  that  the  neo-
plastic cells in LCA express CD31, CD68, and
CD21, whereas they are negative for CD34 and
CD8.
4,5 Our case showed similar findings. 
Although  LCA  frequently  follows  a  benign
course,  cases  with  aggressive  behavior  have
been described, showing a more solid pattern
with nuclear atypia, necrosis, and even distant
metastases several months after splenectomy.
9-10
Therefore,  follow-up  is  recommended.  It  is
interesting to note the rather rapid increase in
the size of the spleen as well as the increase in
the size of existing nodules in our case, as
demonstrated by scans. One can postulate that
this may have reflected a change in the biolo-
gy  of  the  neoplastic  cells.  Gene  profiling  of
clinically benign LCA and those with metastat-
ic disease could help identify poor prognostic
markers.
Littoral cell angioma should be considered
when evaluating a patient with splenomegaly.
A rapidly increasing spleen size, particularly
with cystic features noted on imaging should
suggest the possibility of LCA and the need for
splenectomy. In the future, molecular genetic
studies may provide better understanding of
the etiology and possible therapeutic options. 
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Case Report
Figure 1. (A) Initial computerized tomog-
raphy (CT) scan of the abdomen showing
a  slightly  enlarged  spleen  with  several
poorly defined masses. (B) Second CT scan
of  the  abdomen  showing  a  markedly
enlarged  spleen  with  increased  numbers
and size of intra-splenic nodules. 
Figure 2. Hematoxylin and eosin stain of
the cut surface of the spleen; magnifica-
tion, 200X. Insert: higher magnification of
a sinusoid with the arrow indicating a lit-
toral cell; magnification, 400X.